Diseases, Conditions, Syndromes

Researcher identifies potential cause of 'long COVID'

Even though the COVID-19 public health emergency classification will expire this spring, the lingering effects of the pandemic remain. A constant puzzle to solve since the first year of the pandemic has been "long COVID," ...

Medications

New formulation yields potential long-term HIV protection

For people at high risk of contracting HIV, missing doses of their daily HIV prevention pills can have big consequences. In some cases, missing a pill can lead to lack of protection against the virus.

HIV & AIDS

Stigma and a lack of support limit HIV testing in Côte d'Ivoire

To improve HIV testing rates in the West African country of Côte d'Ivoire, community health workers need more training and support, researchers from the University of Washington School of Medicine in Seattle and the Institute ...

HIV & AIDS

International AIDS relief program, at 20, looks to next steps

Saturday marks a major milestone in the global fight to eliminate the AIDS epidemic, as the U.S. President's Emergency Plan for AIDS Relief celebrates its 20th anniversary as the largest commitment by a country to combat ...

Oncology & Cancer

Preventing cervical cancer

Silent but deadly. These are words often used to describe cervical cancer—a slow-growing disease that rarely causes symptoms in its early stages.

Medications

FDA approves Sunlenca for treatment-resistant HIV

The U.S. Food and Drug Administration has approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with HIV-1 whose HIV infection cannot be successfully treated with other available ...

HIV & AIDS

Task force recommends PrEP for reducing risk for HIV acquisition

The U.S. Preventive Services Task Force (USPSTF) recommends preexposure prophylaxis (PrEP) for reducing the risk for HIV infection among individuals at increased risk for HIV acquisition. This recommendation forms the basis ...

page 10 from 40